Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lycopene Health Claim For Cancer Risk Reduction Requested In Petition

This article was originally published in The Tan Sheet

Executive Summary

There is significant scientific agreement among experts that lycopene is an "effective modifier of the risk of certain cancers," supplement marketer American Longevity states in a June 4 health claim petition to FDA
Advertisement

Related Content

Lawsuit Will Question Supplement Exclusion From Lycopene/Cancer Claims
Lawsuit Will Question Supplement Exclusion From Lycopene/Cancer Claims
Lawsuit Will Question Supplement Exclusion From Lycopene/Cancer Claims
Lycopene decision delayed
Lycopene decision delayed
Lycopene decision delayed
Lycopene cancer study
Lycopene cancer study
Lycopene cancer study

Topics

Advertisement
UsernamePublicRestriction

Register

PS095557

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel